Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Infection and Immunity|September 24, 2004
Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutantsJochen Stritzker, Jozef Janda, Christoph Schoen, et al.
International Journal of Medical Microbiology : IJMM|December 15, 2004
Use of the alpha-hemolysin secretion system of Escherichia coli for antigen delivery in the Salmonella typhi Ty21a vaccine strainIvaylo Gentschev, Guido Dietrich, Simone Spreng, et al.
Plos One|October 24, 2012
Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibodySandeep S Patil, Ivaylo Gentschev, Marion Adelfinger, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 15, 2025
Endogenous gut microbiome and implanted intranasal E. coli-Nissle modulate cancer tissues metabolism in 4T1 syngeneic tumor bearing miceAlexander Cecil, Ivaylo Gentschev, Cornelia Prehn, et al.
Plos One|March 12, 2010
Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regressionKatharina Galmbacher, Martin Heisig, Christian Hotz, et al.
International Journal of Medical Microbiology : IJMM|August 19, 2008
Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coliChristian Hotz, Joachim Fensterle, Werner Goebel, et al.
Journal of Biomedicine & Biotechnology|April 10, 2010
Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann, et al.
BMC Microbiology|July 13, 2011
Specific antibody-receptor interactions trigger InlAB-independent uptake of Listeria monocytogenes into tumor cell linesMartin Heisig, Alexa Frentzen, Birgit Bergmann, et al.
Pageof 4